Led by Sci-tech Innovation, Expanding into Global Markets - Kexing Biopharm in International Exhibitions Shenzhen, China, May 10, 2023 (GLOBE NEWSWIRE) -- As internationalization gradually becomes the mainstream trend of development for China's biopharmaceutical industry, enterprises have intensified...

Cingulate to Present at LD Micro Investor Conference KANSAS CITY, Kan., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...

Global Biopharmaceutical Stability Testing Market Size Brooklyn, New York, Aug. 04, 2022 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Biopharmaceutical Stability Testing Market is...

Cingulate to Present at H.C. Wainwright Global Investment Conference KANSAS CITY, Kan., May 18, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery...

Fibrocor, a MaRS Innovation portfolio company, announces deal with Galapagos Toronto, ON, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Fibrocor Therapeutics, a privately held Canadian company, and Galapagos NV, a Belgo-Dutch pharmaceutical research company, have announced the formation...